Skip to main content
TipRanks
Go Ultimate75% OFF

Elicio Therapeutics (ELTX) Q2 2021 Earnings Report

279 Followers

ELTX Q2 2021 EPS Results

Actual EPS
-$5.80
Consensus EPS
-$6.88
Beat/Miss
Beat by +$1.08
One Year Ago EPS
-$6.86

ELTX Q2 2021 Revenue Results

Actual Revenue
$540.00K
Expected Revenue
$788.00K
Beat/Miss
Missed by -$248.00K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2021
Date
08/12/2021
Time
After Close
Conference Call
Thursday, August 12, 2021
ELTX Upcoming Earnings

Elicio Therapeutics's next earnings date is estimated for March 26, 2027, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

ELTX Earnings History

ELTX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 26, 20272026 (Q4)-0.31--0.45――
Nov 05, 20262026 (Q3)-0.48-0.30-0.650.00% (+0.30)
Aug 13, 20262026 (Q2)-0.54-0.43-0.6634.85% (+0.23)
May 11, 20262026 (Q1)-0.47-0.65-0.8725.29% (+0.22)
Mar 12, 20262025 (Q4)-0.45-0.45-1.0757.94% (+0.62)
Nov 13, 20252025 (Q3)-0.48-0.60-1.3956.83% (+0.79)
Aug 07, 20252025 (Q2)-0.69-0.66-0.64-3.13% (-0.02)
May 13, 20252025 (Q1)―-0.87-1.1524.35% (+0.28)
Mar 31, 20252024 (Q4)-0.83-0.87-1.1524.35% (+0.28)
Nov 13, 20242024 (Q3)-0.73-1.39-1.27-9.45% (-0.12)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed